Parameter | PEID group (N = 94) | UBE group (N = 79) | 95% CI (PEID) | 95% CI (UBE) | t/χ2 | P-value | |
---|---|---|---|---|---|---|---|
VAS for back, mean ± SD | Pre-OP | 5.24 ± 1.44 | 5.34 ± 1.39 | 4.95–5.53 | 5.04–5.64 | -0.45 | 0.65 |
Post-OP (1 month) | 0.78 ± 0.83 | 0.75 ± 0.88 | 0.61–0.95 | 0.56–0.94 | 0.23 | 0.82 | |
Post-OP (6 months) | 0.28 ± 0.50 | 0.19 ± 0.40 | 0.18–0.38 | 0.10–0.28 | 1.28 | 0.20 | |
Post-OP (2 years) | 0.15 ± 0.36 | 0.13 ± 0.34 | 0.08–0.22 | 0.06–0.20 | 0.42 | 0.67 | |
VAS for legs, mean ± SD | Pre-OP | 6.54 ± 1.22 | 6.48 ± 1.23 | 6.29–6.79 | 6.22–6.74 | -1.83 | 0.86 |
Post-OP (1 month) | 1.10 ± 0.83 | 1.14 ± 0.93 | 0.93–1.27 | 0.94–1.34 | -0.33 | 0.75 | |
Post-OP (6 months) | 0.26 ± 0.49 | 0.30 ± 0.54 | 0.16–0.36 | 0.20–0.40 | -0.62 | 0.54 | |
Post-OP (2 years) | 0.22 ± 0.59 | 0.21 ± 0.44 | 0.10–0.34 | 0.12–0.30 | 0.12 | 0.91 | |
ODI, mean ± SD | Pre-OP | 60.93 ± 11.58 | 59.75 ± 11.93 | 58.49–63.37 | 57.07–62.43 | -0.66 | 0.51 |
Post-OP (1 month) | 14.19 ± 8.12 | 14.85 ± 7.93 | 12.62–15.76 | 13.15–16.55 | -0.54 | 0.59 | |
Post-OP (6 months) | 10.81 ± 7.03 | 9.95 ± 5.50 | 9.45–12.17 | 8.73–11.17 | 0.90 | 0.37 | |
Post-OP (2 years) | 6.96 ± 4.68 | 6.23 ± 3.13 | 6.00–7.92 | 5.55–6.91 | 1.20 | 0.23 | |
Modified MacNab criteria | Excellence | 78 | 63 | — | — | 1.17 | 0.82 |
Good | 11 | 13 | — | — | |||
Fair | 2 | 1 | — | — | |||
Poor | 3 | 2 | — | — | |||
Clinical efficacy classification | Excellence and good | 89 | 76 | — | — | 0.23 | 0.73 |
Fair and poor | 5 | 3 | — | — | |||
Complications | Tear of the Dural sac | 2 | 1 | — | — | 1.18 | 0.98 |
Hematoma | 1 | 2 | Â | Â | |||
Sensory abnormalities of the lower limbs | 2 | 2 | — | — | |||
Recurrence | 3 | 2 | — | — |